Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
99 100 Next >
Apple's $100 Million Gamble, Tech Giant Moves to Lift Indonesia's iPhone Ban
Via Benzinga
Tickers AAPL GOOG GOOGL
Under the Radar - November 19th, 2024
Via Benzinga
Tickers KKR
A Look Into Heico Inc's Price Over Earnings
Via Benzinga
Tickers HEI
Kingsoft Cloud Q3 Earnings: Revenue Surges 16%, AI Growth Fuels Profits, CEO Shares Optimistic Outlook
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers KC
BlackRock Spot Bitcoin ETF Options On Nasdaq Rack Up 9-Figure Trading Volume In First Few Hours: 'Seems Very Bullish,' Says Analyst
Via Benzinga
Topics ETFs
Tickers BLK FBTC IBIT MSTR
GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients
Via Benzinga
Tickers GSK
How Is The Market Feeling About Wendy's?
Via Benzinga
Tickers WEN
How Is The Market Feeling About Textron?
Via Benzinga
Tickers TXT
Peering Into Permian Resources's Recent Short Interest
Via Benzinga
Tickers PR
Joby Aviation Positioned For Air Taxi Leadership, Thanks To FAA Backing And Uber Partnership: Analyst
Via Benzinga
Tickers ARKX JOBY UBER WBAT
EXCLUSIVE: Anthony Pompliano Calls For US To Buy $250B Bitcoin On Day 1 Of Trump Administration: 'Protect Our Future, It's Such A No Brainer'
Via Benzinga
Topics Government
Exposures Political
Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients
Via Benzinga
Tickers MRK
Suze Orman Warns $3 Million Isn't Enough For Retirement, Even At A Mere 3% Withdrawal Rate – She Says You Need $10 Million Or More
Via Benzinga
Topics Retirement
Exposures Pension
Eli Lilly's Investigational Drug Cuts Sticky Cholesterol Levels By Almost 86%
Via Benzinga
Tickers LLY
Cracking The Code: Understanding Analyst Reviews For Reddit
Via Benzinga
Tickers RDDT
Critical Insights From Synchrony Finl Analyst Ratings: What You Need To Know
Via Benzinga
Tickers SYF
Spotlight on Boeing: Analyzing the Surge in Options Activity
Via Benzinga
Tickers BA
Tryptamine Therapeutics Advances Psilocin-Based IV Infusion To Phase 2 Clinical Trials
Via Benzinga
Tickers TYPTF
What's Going On With Incyte Shares Tuesday?
Via Benzinga
Tickers INCY
Qualcomm Unusual Options Activity
Via Benzinga
Tickers QCOM
Navigating 26 Analyst Ratings For Guidewire Software
Via Benzinga
Tickers GWRE
Cracking The Code: Understanding Analyst Reviews For TriplePoint Venture Gwth
Via Benzinga
Tickers TPVG
The Analyst Landscape: 8 Takes On Bread Finl Hldgs
Via Benzinga
Tickers BFH
Unveiling 15 Analyst Insights On Arch Capital Group
Via Benzinga
Tickers ACGL
Why Is Fusion Fuel Green Stock Falling Today?
Via Benzinga
Tickers HTOO QIND
PainReform Stock Is Soaring Tuesday: What's Going On?
Via Benzinga
Tickers PRFX
Walmart's Q3 Performance Shows Structural Gains Fueling Future Growth: Analyst
Via Benzinga
Tickers FSTA JPM VDC WMT
What's Going On With Symbotic Shares Today?
Via Benzinga
Tickers SYM
Dell Hits A Golden Cross: Can It Power Through Earnings Week?
Via Benzinga
Tickers DELL NVDA
Nvidia's Collaboration with Google AI Advances Next-Gen Quantum Hardware
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers GOOG GOOGL META MSFT
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.